← Evidence map

ArticleOncotarget2018

MELK is a novel therapeutic target in high-risk neuroblastoma.

Shan Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29416794